TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35674760

Group type: EXPERIMENTAL
Intervention: Tazarotene 0.045% lotion
Number of subjects: 1079

Group type: COMPARATOR
Intervention: Vehicle lotion
Number of subjects: 1079
Study: 33681988

Group type: EXPERIMENTAL
Intervention: AMH modulation (recombinant human AMH protein supplementation during the secondary-to-early antral stage followed by neutralizing anti-human AMH antibody)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (no AMH modulation)
Number of subjects: 19
Study: 32716061

Group type: EXPERIMENTAL
Intervention: Test group (sutured apically to the periosteum)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (flap margin left free)
Number of subjects: 28
Study: 34053095

Group type: EXPERIMENTAL
Intervention: Leaflet-based intervention ‘Hypos can strike twice’ provided by ambulance personnel
Number of subjects: 4825

Group type: EXPERIMENTAL
Intervention: Leaflet-based intervention ‘Hypos can strike twice’
Number of subjects: 4825
Study: 35723748

Group type: EXPERIMENTAL
Intervention: Ceramic bone graft substitute (CBGS)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Iliac crest bone graft autograft
Number of subjects: 45
Study: 34428334

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided adductor canal block with 0.25% bupivacaine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided adductor canal block with 0.16% bupivacaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no adductor canal block)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: All groups (including control)
Number of subjects: 60
Study: 36190377

Group type: EXPERIMENTAL
Intervention: Tacrolimus (Tac), Mycophenolate mofetil (MMF), and Prednisolone (TMP)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Tacrolimus (Tac), Sirolimus (SRL), and Prednisolone (TSP)
Number of subjects: 38
Study: 33774715

Group type: EXPERIMENTAL
Intervention: Colgate Total 12 (CT)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Body Kingdom (BK)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Black is White (BW)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Colgate optic white (COW)
Number of subjects: 48
Study: 35639174

Group type: EXPERIMENTAL
Intervention: Romosozumab
Number of subjects: 339
Study: 33004382

Group type: EXPERIMENTAL
Intervention: Low-load blood flow restricted exercise (BFRE) for 8 weeks preoperatively
Number of subjects: 84

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 84
Study: 36592046

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 3158
Study: 34076641

Group type: EXPERIMENTAL
Intervention: Buccal pedicle flap
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Connective tissue graft
Number of subjects: 40

Group type: COMPARATOR
Intervention: No soft tissue grafting or plastic surgery
Number of subjects: 40
Study: 32229185

Group type: EXPERIMENTAL
Intervention: Air-powered positioning system with wedges
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ceiling lift with pillows
Number of subjects: 0
Study: 34520250

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 109

Group type: COMPARATOR
Intervention: Lithium
Number of subjects: 109
Study: 33207580

Group type: EXPERIMENTAL
Intervention: Tai Chi with Thera-Band (TCTB) exercise
Number of subjects: 40

Group type: COMPARATOR
Intervention: Tai Chi exercise only
Number of subjects: 40
Study: 33143432

Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 50
Study: 32364756

Group type: EXPERIMENTAL
Intervention: Sunitinib
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: TGC perfusion chemotherapy
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Sunitinib + TGC perfusion chemotherapy
Number of subjects: 150
Study: 35686189

Group type: EXPERIMENTAL
Intervention: Online remote behavior therapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Face-to-face behavior therapy
Number of subjects: 40
Study: 32856190

Group type: EXPERIMENTAL
Intervention: FA + DHA (FA 800 μg/d + DHA 800 mg/d)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: FA (FA 800 μg/d)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: DHA (DHA 800 mg/d)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study: 32352391

Group type: EXPERIMENTAL
Intervention: Digital CBT group (n=45)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (n=25)
Number of subjects: 70
Study: 36458132

Group type: EXPERIMENTAL
Intervention: 0.1% menthol gel
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 0.3% menthol gel
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 0.5% menthol gel
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 0.7% menthol gel
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: All menthol gels
Number of subjects: 27

Group type: COMPARATOR
Intervention: CON (non-menthol, flavor-matched placebo)
Number of subjects: 27
Study: 32701392

Group type: EXPERIMENTAL
Intervention: Curcumin (CUR)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 23
Study: 34545696

Group type: EXPERIMENTAL
Intervention: Subjective Global Assessment score (SGA)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Short Nutritional Assessment Questionnaire (SNAQ)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: INSYST2 score
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Subjective Global Assessment score (SGA) in multivariate analysis
Number of subjects: 116
Study: 35702815

Group type: EXPERIMENTAL
Intervention: Mother vignette
Number of subjects: 270

Group type: COMPARATOR
Intervention: Foster care vignette
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: PTSD diagnosis
Number of subjects: 270
Study: 33431262

Group type: EXPERIMENTAL
Intervention: Pain-analgesics treatment
Number of subjects: 463

Group type: EXPERIMENTAL
Intervention: Pain-no analgesics
Number of subjects: 463

Group type: EXPERIMENTAL
Intervention: No pain-analgesics treatment
Number of subjects: 463

Group type: EXPERIMENTAL
Intervention: No pain-no analgesics
Number of subjects: 463

Group type: EXPERIMENTAL
Intervention: Pain intensity scores
Number of subjects: 463
Study: 32051492

Group type: EXPERIMENTAL
Intervention: NAC plus CCRT
Number of subjects: 1378

Group type: COMPARATOR
Intervention: NAC plus IMRT alone
Number of subjects: 1378
Study: 35095011

Group type: EXPERIMENTAL
Intervention: Trataka (Yogic visual concentration) practice
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 106
Study: 34057124

Group type: EXPERIMENTAL
Intervention: Dorsata honey (DH) given orally three times a day at a dose of 15 ml
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 30
Study: 36113170

Group type: EXPERIMENTAL
Intervention: Intrathecal cell treatments (NurOwn®)
Number of subjects: 18
Study: 32198929

Group type: EXPERIMENTAL
Intervention: NICOM
Number of subjects: 75

Group type: COMPARATOR
Intervention: Echocardiographic
Number of subjects: 75

Group type: COMPARATOR
Intervention: Empirical
Number of subjects: 75
Study: 33826038

Group type: EXPERIMENTAL
Intervention: Adapted Cognitive Behavioral Therapy (CBT)
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Standard Cognitive Behavioral Therapy (CBT)
Number of subjects: 167

Group type: COMPARATOR
Intervention: Treatment-as-usual
Number of subjects: 167
Study: 33896589

Group type: COMPARATOR
Intervention: Esketamine and placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Esketamine and sodium nitroprusside
Number of subjects: 20

Group type: COMPARATOR
Intervention: Racemic ketamine and placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Racemic ketamine and sodium nitroprusside
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: S-norketamine
Number of subjects: 20
Study: 36314686

Group type: EXPERIMENTAL
Intervention: Target systolic blood pressure <120 mm Hg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Target systolic blood pressure <140/90 mm Hg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Target systolic blood pressure <130/80 mm Hg
Number of subjects: 0
Study: 35131013

Group type: EXPERIMENTAL
Intervention: Systematic graded rewarming measures
Number of subjects: 104

Group type: COMPARATOR
Intervention: Traditional rewarming measures
Number of subjects: 104
Study: 36421345

Group type: EXPERIMENTAL
Intervention: Stereotactic Body Radiotherapy (SBRT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Transcatheter arterial (chemo-) embolization (TAE/TACE)
Number of subjects: 40
Study: 34511121

Group type: EXPERIMENTAL
Intervention: Educational programme (2-month duration)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 196
Study: 32507446

Group type: EXPERIMENTAL
Intervention: Phytosomal curcumin (250 mg/day) for 8 weeks
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo for 8 weeks
Number of subjects: 54
Study: 35037118

Group type: COMPARATOR
Intervention: Non-washing group (Group 1)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Washing with water alone group (Group 2)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Washing with water and soap group (Group 3)
Number of subjects: 168
Study: 33712224

Group type: EXPERIMENTAL
Intervention: Opioid-free anaesthesia
Number of subjects: 146

Group type: COMPARATOR
Intervention: Opioid-based anaesthesia
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Opioid-free anaesthesia and Opioid-based anaesthesia
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Obesity
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: High D'Amico risk
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Stage 3 tumour pathology
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: N1 status
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Positive surgical margins
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Anaesthesia technique
Number of subjects: 146
Study: 32424878

Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT-I)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Waitlist control (WLC)
Number of subjects: 136
Study: 34534510

Group type: EXPERIMENTAL
Intervention: Telemedicine management using mobile phone
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control group with routine intervention
Number of subjects: 97
Study: 33145753

Group type: EXPERIMENTAL
Intervention: LEEP+TH
Number of subjects: 5330

Group type: COMPARATOR
Intervention: LEEP
Number of subjects: 5330
Study: 36130300

Group type: EXPERIMENTAL
Intervention: Ixazomib maintenance
Number of subjects: 1280

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1280
Study: 33004749

Group type: EXPERIMENTAL
Intervention: Vinorelbine plus capecitabine (NX)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Docetaxel plus capecitabine (TX)
Number of subjects: 97
Study: 34952708

Group type: EXPERIMENTAL
Intervention: Olaparib plus bevacizumab
Number of subjects: 806

Group type: COMPARATOR
Intervention: Bevacizumab alone
Number of subjects: 806
Study: 33723117

Group type: EXPERIMENTAL
Intervention: Botulinum toxin injection
Number of subjects: 40

Group type: COMPARATOR
Intervention: Occlusal splint
Number of subjects: 40
Study: 32536118

Group type: EXPERIMENTAL
Intervention: Prone position extubation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Supine position extubation
Number of subjects: 60
Study: 33594185

Group type: EXPERIMENTAL
Intervention: Nonsurgical treatment
Number of subjects: 128

Group type: COMPARATOR
Intervention: Surgical treatment
Number of subjects: 128
Study: 32808383

Group type: EXPERIMENTAL
Intervention: 12-week multi-component physical activity module (including a Fitbit tracker and customized email feedback)
Number of subjects: 50
Study: 35343269

Group type: EXPERIMENTAL
Intervention: CGM+FBI
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standard-CGM
Number of subjects: 0

Group type: COMPARATOR
Intervention: BGM-Crossover
Number of subjects: 0
Study: 33537703

Group type: EXPERIMENTAL
Intervention: Obturator nerve block (ONB)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Neuromuscular block (NMB)
Number of subjects: 60
Study: 32398024

Group type: EXPERIMENTAL
Intervention: Supervised Exercise (SE)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Web-based Exercise (WE)
Number of subjects: 77
Study: 34980598

Group type: EXPERIMENTAL
Intervention: Fulvestrant plus sapanisertib 4 mg daily
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Fulvestrant plus sapanisertib 30 mg weekly
Number of subjects: 141

Group type: COMPARATOR
Intervention: Fulvestrant 500 mg (control)
Number of subjects: 141
Study: 32387326

Group type: EXPERIMENTAL
Intervention: Music and landscape image in postoperative hospital rooms
Number of subjects: 133

Group type: COMPARATOR
Intervention: Standard hospital room without music or landscape
Number of subjects: 133
Study: 32127847

Group type: EXPERIMENTAL
Intervention: Intravenous ondansetron weight adjusted dosing at 0.1mg/kg
Number of subjects: 124

Group type: COMPARATOR
Intervention: Fixed dose of 4mg ondansetron
Number of subjects: 124
Study: 35093978

Group type: EXPERIMENTAL
Intervention: Oculus Go
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Oculus Quest
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Lenovo Mirage Solo
Number of subjects: 9

Group type: COMPARATOR
Intervention: Comparison between headsets
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: All headsets
Number of subjects: 9
Study: 34477818

Group type: EXPERIMENTAL
Intervention: Avelumab (anti-PD-L1) administered at various doses: 70 mg, 350 mg, 500 mg every 2 weeks; 500 mg every 3 weeks; and 10 mg/kg every 2 weeks.
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Avelumab (anti-PD-L1) administered at various doses.
Number of subjects: 31
Study: 32289353

Group type: EXPERIMENTAL
Intervention: Risk of contamination framework
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Therapist in the intervention arm
Number of subjects: 100
Study: 35640729

Group type: EXPERIMENTAL
Intervention: ACE inhibitors (ACEi)
Number of subjects: 1999

Group type: EXPERIMENTAL
Intervention: Beta-blockers
Number of subjects: 1999
Study: 32586079

Group type: EXPERIMENTAL
Intervention: Tai Chi exercise for 30 minutes, 5 times weekly for 48 weeks
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Tai Chi exercise for 60 minutes, 5 times weekly for 48 weeks
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (no Tai Chi)
Number of subjects: 52
Study: 35924272

Group type: EXPERIMENTAL
Intervention: Comprehensive intervention
Number of subjects: 400

Group type: COMPARATOR
Intervention: Routine public health crisis intervention measures
Number of subjects: 400
Study: 32312152

Group type: EXPERIMENTAL
Intervention: Male cyberbully/male cybervictim
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Male cyberbully/female cybervictim
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Female cyberbully/male cybervictim
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Female cyberbully/female cybervictim
Number of subjects: 176
Study: 32046755

Group type: EXPERIMENTAL
Intervention: Prophylactic augmentation of the wound with absorbable mesh
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Absorbable mesh
Number of subjects: 0

Group type: COMPARATOR
Intervention: Biologic/biosynthetic meshes
Number of subjects: 0
Study: 35377929

Group type: EXPERIMENTAL
Intervention: Music intervention (listened to music in the waiting room until immediately before IVS)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Nonmusic (did not listen to music)
Number of subjects: 60
Study: 34423347

Group type: EXPERIMENTAL
Intervention: 3D radiomics model
Number of subjects: 146

Group type: COMPARATOR
Intervention: Qualitative analysis (mrEMVI and sphincter invasion)
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Radiomics models (all three models)
Number of subjects: 146
Study: 32957336

Group type: EXPERIMENTAL
Intervention: 10 days of standard triple therapy (STT) using ilaprazole (10 mg ilaprazole, 500 mg clarithromycin, and 1000 mg amoxicillin twice daily)
Number of subjects: 254

Group type: COMPARATOR
Intervention: 7 days of standard triple therapy (STT) using ilaprazole (10 mg ilaprazole, 500 mg clarithromycin, and 1000 mg amoxicillin twice daily)
Number of subjects: 254
Study: 35148357

Group type: EXPERIMENTAL
Intervention: Empagliflozin 25 mg for 12 weeks
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Empagliflozin 25 mg
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 33027078

Group type: EXPERIMENTAL
Intervention: Functional dyspepsia (postprandial distress syndrome)
Number of subjects: 4562

Group type: EXPERIMENTAL
Intervention: Functional dyspepsia (epigastric pain syndrome)
Number of subjects: 4562

Group type: EXPERIMENTAL
Intervention: Gastroesophageal reflux disease
Number of subjects: 4562
Study: 36324245

Group type: EXPERIMENTAL
Intervention: MD-7246 300 μg
Number of subjects: 388

Group type: EXPERIMENTAL
Intervention: MD-7246 600 μg
Number of subjects: 388

Group type: EXPERIMENTAL
Intervention: MD-7246 1200 μg
Number of subjects: 388

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 388
Study: 33632268

Group type: EXPERIMENTAL
Intervention: Pediatric integrative manual therapy (PIMT) combined with caregiver education program
Number of subjects: 34

Group type: COMPARATOR
Intervention: Caregiver education program only
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 34
Study: 35313926

Group type: EXPERIMENTAL
Intervention: Urgent chest X-ray
Number of subjects: 11

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 11
Study: 32529753

Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low-fat diet
Number of subjects: 0
Study: 35043692

Group type: EXPERIMENTAL
Intervention: Hyperglycemia (≥180 mg/dL)
Number of subjects: 4878

Group type: EXPERIMENTAL
Intervention: Dual antiplatelet therapy
Number of subjects: 4878

Group type: COMPARATOR
Intervention: Normoglycemia (<180 mg/dL)
Number of subjects: 4878
Study: 34558624

Group type: EXPERIMENTAL
Intervention: High plasma 25-hydroxyvitamin D (25(OH)D) levels in normal fasting blood glucose (NFG) group
Number of subjects: 591

Group type: EXPERIMENTAL
Intervention: High plasma 25-hydroxyvitamin D (25(OH)D) levels in impaired fasting glucose (IFG) group
Number of subjects: 591

Group type: EXPERIMENTAL
Intervention: Diabetes with low plasma 25-hydroxyvitamin D (25(OH)D) levels
Number of subjects: 591

Group type: EXPERIMENTAL
Intervention: Combined group of IFG and diabetes
Number of subjects: 591

Group type: EXPERIMENTAL
Intervention: Ischemic stroke
Number of subjects: 591
Study: 33249498

Group type: EXPERIMENTAL
Intervention: Reduced nicotine content (RNC) study cigarettes tapered every three weeks to a final VLNC (0.2 mg/cigarette) for six weeks
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Reduced nicotine content (RNC) study cigarettes
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Compliant VLNC smokers
Number of subjects: 245

Group type: COMPARATOR
Intervention: Usual nicotine content (UNC) study cigarettes (11.6 mg/cigarette)
Number of subjects: 245
Study: 32236521

Group type: EXPERIMENTAL
Intervention: 4-Cl-KYN monotherapy (1080 mg/d for 7 days, then 1440 mg/d for 7 days)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 34610387

Group type: EXPERIMENTAL
Intervention: Intensity-Modulated Radiation Therapy (IMRT)
Number of subjects: 658

Group type: COMPARATOR
Intervention: 3-Dimensional Conformal Radiation Therapy (3DCRT)
Number of subjects: 658
Study: 34421675

Group type: EXPERIMENTAL
Intervention: Placebo + Ayahuasca
Number of subjects: 30

Group type: COMPARATOR
Intervention: Ayahuasca
Number of subjects: 30

Group type: COMPARATOR
Intervention: Cannabidiol (CBD) + Ayahuasca
Number of subjects: 30
Study: 33667037

Group type: EXPERIMENTAL
Intervention: Liberal gender ideology
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: Liberal men
Number of subjects: 342
Study: 35692201

Group type: EXPERIMENTAL
Intervention: Deep learning and back propagation (BP) neural network model for predicting acute exacerbation of COPD
Number of subjects: 1326

Group type: EXPERIMENTAL
Intervention: Deep learning and BP neural network model for predicting acute exacerbation of COPD
Number of subjects: 1326
Study: 35291408

Group type: EXPERIMENTAL
Intervention: Higher than baseline preoperative blood pressure (MAP allowed to increase up to 20% higher than baseline MAP by inducing pneumoperitoneum)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Normal to low blood pressure (MAP deliberately controlled at a tight limit from normal baseline MAP values to 20% less than baseline by titrating TNG infusion)
Number of subjects: 72
Study: 35039498

Group type: EXPERIMENTAL
Intervention: Ketamine infusion (placebo-controlled)
Number of subjects: 0
Study: 35404188

Group type: EXPERIMENTAL
Intervention: Randomized basket trial design with family wise error rate control at 0.025k
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomized confirmatory basket trials
Number of subjects: 0
Study: 33927114

Group type: EXPERIMENTAL
Intervention: Strength, Power, and Hypertrophy (SPH) group
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Strength, Power, and Functional (SP + Func) group
Number of subjects: 35
Study: 32302261

Group type: EXPERIMENTAL
Intervention: Child disclosure
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Teacher disclosure
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Mother disclosure
Number of subjects: 217

Group type: COMPARATOR
Intervention: Control (no stuttering disclosure)
Number of subjects: 217
Study: 32116252

Group type: EXPERIMENTAL
Intervention: Procedural Learning Skill (PLSC) task
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Visual-motor reaction times
Number of subjects: 26
Study: 36006858

Group type: EXPERIMENTAL
Intervention: The Real Cost vaping prevention ads
Number of subjects: 623

Group type: EXPERIMENTAL
Intervention: The Real Cost smoking prevention ads
Number of subjects: 623
Study: 34380790

Group type: EXPERIMENTAL
Intervention: Intermittent phototherapy (IPT) (one hour on and two hours off)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Continuous phototherapy (CPT) (with minimum interruptions for feeding)
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Intermittent phototherapy (IPT)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Continuous phototherapy (CPT)
Number of subjects: 174
Study: 32966585

Group type: EXPERIMENTAL
Intervention: Gabapentin enacarbil (GEn)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0